StemCells, Inc. Reports Second Quarter 2015 Financial Results, Business Update and Clinical Program Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to StemCells, Inc. Reports Second Quarter 2015 Financial Results, Business Update and Clinical Program Highlights

StemCells (STEM) Reports In-Line Q2 EPS

August 6, 2015 4:36 PM EDT

StemCells (NASDAQ: STEM) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $30 thousand.

"Our clinical programs achieved several key milestones since our last earnings release," reported StemCells... More